| Dr Jason L Lane, MD | |
|
400 Wabash Ave, Akron, OH 44307-2433 | |
| (330) 344-7611 | |
| (440) 344-6418 |
| Full Name | Dr Jason L Lane |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 14 Years |
| Location | 400 Wabash Ave, Akron, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972815058 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 35.122748 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Akron General Medical Center | Akron, OH | Hospital |
| Medina Hospital | Medina, OH | Hospital |
| Mercy Medical Center | Canton, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cleveland Clinic Foundation | 1850203555 | 5690 |
News Archive
A pharmacological interaction occurs when the effects of a one drug are modified by the presence of another. The consequences can be harmful if the interaction causes an increase in the toxicity of the drug or if it diminishes its effect, possibly even causing the patient's death, in the worst case scenario. At present, there are databases for checking possible interactions between drugs administered to patients, but the main problem is that many of the databases are not updated for three years.
Avila Therapeutics, Inc., a biotechnology company developing novel targeted covalent drugs, presented results today of preclinical studies that demonstrate its orally-available targeted covalent drug candidate, AVL-192, achieves superior potency against drug-resistant mutations of the Hepatitis C Virus (HCV). These new data were presented today at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) international meeting in Boston, Massachusetts.
Bacteria know that they are too small to make an impact individually. So they wait, they multiply, and then they engage in behaviors that are only successful when all cells participate in unison. There are hundreds of behaviors that bacteria carry out in such communities. Now researchers at Rockefeller University have discovered one that has never been observed or described before in a living system.
Janssen Inc. announced today that PREZCOBIX (darunavir/cobicistat), a once-daily, oral medication for the treatment of HIV infection in combination with other antiretroviral agents, is now available in Canada. It is the first HIV treatment option available to patients that provides boosted darunavir in a single tablet.
› Verified 8 days ago
| Entity Name | The Cleveland Clinic Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679525919 PECOS PAC ID: 1850203555 Enrollment ID: O20031103000049 |
News Archive
A pharmacological interaction occurs when the effects of a one drug are modified by the presence of another. The consequences can be harmful if the interaction causes an increase in the toxicity of the drug or if it diminishes its effect, possibly even causing the patient's death, in the worst case scenario. At present, there are databases for checking possible interactions between drugs administered to patients, but the main problem is that many of the databases are not updated for three years.
Avila Therapeutics, Inc., a biotechnology company developing novel targeted covalent drugs, presented results today of preclinical studies that demonstrate its orally-available targeted covalent drug candidate, AVL-192, achieves superior potency against drug-resistant mutations of the Hepatitis C Virus (HCV). These new data were presented today at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) international meeting in Boston, Massachusetts.
Bacteria know that they are too small to make an impact individually. So they wait, they multiply, and then they engage in behaviors that are only successful when all cells participate in unison. There are hundreds of behaviors that bacteria carry out in such communities. Now researchers at Rockefeller University have discovered one that has never been observed or described before in a living system.
Janssen Inc. announced today that PREZCOBIX (darunavir/cobicistat), a once-daily, oral medication for the treatment of HIV infection in combination with other antiretroviral agents, is now available in Canada. It is the first HIV treatment option available to patients that provides boosted darunavir in a single tablet.
› Verified 8 days ago
| Entity Name | Wooster Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033135009 PECOS PAC ID: 6800708124 Enrollment ID: O20031211000578 |
News Archive
A pharmacological interaction occurs when the effects of a one drug are modified by the presence of another. The consequences can be harmful if the interaction causes an increase in the toxicity of the drug or if it diminishes its effect, possibly even causing the patient's death, in the worst case scenario. At present, there are databases for checking possible interactions between drugs administered to patients, but the main problem is that many of the databases are not updated for three years.
Avila Therapeutics, Inc., a biotechnology company developing novel targeted covalent drugs, presented results today of preclinical studies that demonstrate its orally-available targeted covalent drug candidate, AVL-192, achieves superior potency against drug-resistant mutations of the Hepatitis C Virus (HCV). These new data were presented today at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) international meeting in Boston, Massachusetts.
Bacteria know that they are too small to make an impact individually. So they wait, they multiply, and then they engage in behaviors that are only successful when all cells participate in unison. There are hundreds of behaviors that bacteria carry out in such communities. Now researchers at Rockefeller University have discovered one that has never been observed or described before in a living system.
Janssen Inc. announced today that PREZCOBIX (darunavir/cobicistat), a once-daily, oral medication for the treatment of HIV infection in combination with other antiretroviral agents, is now available in Canada. It is the first HIV treatment option available to patients that provides boosted darunavir in a single tablet.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jason L Lane, MD 30701 Lorain Rd Ste A, North Olmsted, OH 44070-6325 Ph: (440) 274-5000 | Dr Jason L Lane, MD 400 Wabash Ave, Akron, OH 44307-2433 Ph: (330) 344-7611 |
News Archive
A pharmacological interaction occurs when the effects of a one drug are modified by the presence of another. The consequences can be harmful if the interaction causes an increase in the toxicity of the drug or if it diminishes its effect, possibly even causing the patient's death, in the worst case scenario. At present, there are databases for checking possible interactions between drugs administered to patients, but the main problem is that many of the databases are not updated for three years.
Avila Therapeutics, Inc., a biotechnology company developing novel targeted covalent drugs, presented results today of preclinical studies that demonstrate its orally-available targeted covalent drug candidate, AVL-192, achieves superior potency against drug-resistant mutations of the Hepatitis C Virus (HCV). These new data were presented today at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) international meeting in Boston, Massachusetts.
Bacteria know that they are too small to make an impact individually. So they wait, they multiply, and then they engage in behaviors that are only successful when all cells participate in unison. There are hundreds of behaviors that bacteria carry out in such communities. Now researchers at Rockefeller University have discovered one that has never been observed or described before in a living system.
Janssen Inc. announced today that PREZCOBIX (darunavir/cobicistat), a once-daily, oral medication for the treatment of HIV infection in combination with other antiretroviral agents, is now available in Canada. It is the first HIV treatment option available to patients that provides boosted darunavir in a single tablet.
› Verified 8 days ago
Dr. Thomas Hlivko, Pathology Medicare: Accepting Medicare Assignments Practice Location: 2215 E Waterloo Rd, Ste 313, Akron, OH 44312 Phone: 330-208-2720 Fax: 330-208-2721 | |
Dr. William Arthur Henthorne, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-3786 Fax: 330-375-4874 | |
Eric Douglas Speakman, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 400 Wabash Ave, Akron, OH 44307 Phone: 330-344-2025 Fax: 330-344-6418 | |
Dr. Steven Michael Thompson, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-9678 | |
Dr. Caroline Mitchell Abramovich, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-3786 Fax: 330-375-4874 | |
Silvia Deperalta, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-3786 Fax: 330-375-4874 | |
Dimitris P Agamanolis, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-8572 Fax: 330-543-3226 |